Page last updated: 2024-08-16

ribavirin and Depressive Disorder, Major

ribavirin has been researched along with Depressive Disorder, Major in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (42.31)29.6817
2010's13 (50.00)24.3611
2020's2 (7.69)2.80

Authors

AuthorsStudies
Bugajska, J; Inglot, M; Janocha-Litwin, J; Malyszczak, K; Marciniak, D; Pawlak, D; Pawlowski, T; Zalewska, M1
Baumert, TF; Berg, T; Brants, L; Buggisch, P; Discher, T; Friebe, A; Fromm, G; Kemper, J; Lieb, K; Link, R; Ockenga, J; Reimer, J; Rentrop, M; Sarkar, R; Sarkar, S; Schaefer, M; Schläpfer, T; Spengler, U; Weidenbach, H; Zeuzem, S1
Fialho, R; Harrison, N; Pereira, M; Rusted, J; Whale, R1
Frydecka, D; Hadryś, T; Inglot, M; Małyszczak, K; Pawłowski, T1
Avasthi, A; Chawla, YK; Grover, S; Mahajan, S1
Cozzolongo, R; Giannuzzi, V; Lanzilotta, E; Leandro, G; Porcelli, P1
Burridge, A; Fialho, R; File, A; Keller, M; Pereira, M; Tibble, J; Whale, R1
Eccles, J; Fialho, R; File, A; Haq, I; Keller, M; Pereira, M; Rolt, M; Tibble, J; Whale, R1
A, Y; E, F; GM, Sel-D; H, AG; M, A; MM, B; MM, el-S; U, Y1
Batista-Neves, S; de Oliveira, IR; Galvão-de Almeida, A; Guindalini, C; Lyra, AC; Miranda-Scippa, A; Paraná, R; Quarantini, LC1
Kenis, G; Koek, GH; Prickaerts, J; Robaeys, G; Steinbusch, HW; van Os, J; Wichers, M1
Bech, P; Buhl, MR; Färkkilä, M; Hellstrand, K; Hjerrild, S; Lagging, M; Langeland, N; Leutscher, PD; Mørch, K; Norkrans, G; Pedersen, C1
Ardèvol, M; Castellví, P; Costa, J; Diago, M; Diez-Quevedo, C; Giménez, D; Giner, P; Martín-Santos, R; Masnou, H; Morillas, RM; Navinés, R; Planas, R; Pretel, J; Solà, R1
Barton, D; Dore, G; Kronborg, I; Sasadeusz, JJ; Weltman, M; Yoshihara, M1
Rifai, MA; Sabouni, MA1
Berg, T; Garkisch, AS; Heinz, A; Hinzpeter, A; Pich, M; Schaefer, M; Schwaiger, M; Uebelhack, R; van Boemmel, F1
Hauser, P; Loftis, JM; Rifai, MA1
Balderson, K; Sockalingam, S1
Asnis, GM; De La Garza, R1
Bernard, PH; Castera, L; Champbenoit, P; Constant, A; Couzigou, P; De Ledinghen, V; Demotes-Mainard, J; Henry, C1
Hauser, P; Indest, DW; Loftis, JM; Moles, JK; Morasco, BJ; Rifai, MA1
Amore, M; Baldini, A; Beverini, E; Bonino, F; Brunetto, M; Carlini, M; Del Debbio, A; Dell'Osso, L; Ferrari, G; Maggi, L; Maj, M; Manca, E; Pini, S; Rucci, P; Scarallo, V; Semeraro, Q1
Aszalós, Z; Lengyel, G; Tulassay, Z1
Asnis, GM; Borisov, AS; Bruno, CJ; Demetrashvili, MF; Evans, DL; Henderson, MA; Miller, AH; Raison, CL; Reinus, JF; Staab, JP; Weinreib, R; Woolwine, BJ; Zajecka, JM1
Batista-Neves, S; Bressan, RA; Galvão, A; Miranda-Scippa, A; Paraná, R; Quarantini, LC1
Saunders, JC1

Reviews

4 review(s) available for ribavirin and Depressive Disorder, Major

ArticleYear
Utilizing genomic polymorphisms to personalize hepatitis C therapies.
    Current opinion in organ transplantation, 2012, Volume: 17, Issue:2

    Topics: Antiviral Agents; Depressive Disorder, Major; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Pharmacogenetics; Polymorphism, Genetic; Ribavirin; Treatment Outcome; Viral Load

2012
Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.
    Journal of clinical gastroenterology, 2006, Volume: 40, Issue:4

    Topics: Anemia; Antiviral Agents; Depressive Disorder, Major; Hepatitis C, Chronic; Humans; Intercellular Adhesion Molecule-1; Interferon alpha-2; Interferon Type I; Interferon-alpha; Nitric Oxide; Paroxetine; Peptide Hydrolases; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thyroid Diseases

2006
[Hepatitis C viral infection and depression].
    Orvosi hetilap, 2007, Jan-07, Volume: 148, Issue:1

    Topics: Antidepressive Agents; Antiviral Agents; Depressive Disorder, Major; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin

2007
Neuropsychiatric symptoms of hepatitis C.
    Issues in mental health nursing, 2008, Volume: 29, Issue:3

    Topics: Antiviral Agents; Anxiety Disorders; Brain; Chronic Disease; Cognition Disorders; Depressive Disorder, Major; Hepatitis C; Humans; Neuropsychological Tests; Ribavirin

2008

Trials

10 trial(s) available for ribavirin and Depressive Disorder, Major

ArticleYear
The role of alexithymia in quality of life impairment in patients with chronic hepatitis C during antiviral treatment.
    Comprehensive psychiatry, 2015, Volume: 60

    Topics: Affective Symptoms; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Stress, Psychological

2015
Major depressive disorder and generalized anxiety disorder and response to treatment in hepatitis C patients in Egypt.
    International journal of psychiatry in medicine, 2015, Volume: 50, Issue:2

    Topics: Adult; Antiviral Agents; Anxiety Disorders; Depressive Disorder, Major; Egypt; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Treatment Outcome; Young Adult

2015
Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
    The international journal of neuropsychopharmacology, 2011, Volume: 14, Issue:2

    Topics: Antiviral Agents; Brain-Derived Neurotrophic Factor; Cytokines; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Hydrocortisone; Immunologic Factors; Interferon-alpha; Male; Psychiatric Status Rating Scales; Ribavirin; Time Factors

2011
Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial.
    The Journal of clinical psychiatry, 2011, Volume: 72, Issue:4

    Topics: Adult; Antiviral Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Treatment Outcome

2011
Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy.
    Addiction (Abingdon, England), 2011, Volume: 106, Issue:5

    Topics: Adult; Analgesics, Opioid; Antiviral Agents; Australia; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Opiate Substitution Treatment; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome

2011
Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
    Journal of hepatology, 2005, Volume: 42, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Antiviral Agents; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Dropouts; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors

2005
A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.
    Journal of affective disorders, 2007, Volume: 103, Issue:1-3

    Topics: Adult; Antidepressive Agents, Second-Generation; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Paroxetine; Personality Inventory; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Veterans

2007
Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders.
    Journal of psychosomatic research, 2007, Volume: 62, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Ribavirin; Risk Factors; Statistics as Topic

2007
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
    Alimentary pharmacology & therapeutics, 2007, May-15, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Depressive Disorder, Major; Double-Blind Method; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Paroxetine; Ribavirin

2007
Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:8

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepatitis C; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Panic Disorder; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Time Factors; Treatment Failure

2007

Other Studies

12 other study(ies) available for ribavirin and Depressive Disorder, Major

ArticleYear
The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
    Journal of psychiatry & neuroscience : JPN, 2021, 01-18, Volume: 46, Issue:1

    Topics: Adult; Antiviral Agents; Cross-Sectional Studies; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Immunologic Factors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Kynurenic Acid; Kynurenine; Longitudinal Studies; Male; Middle Aged; ortho-Aminobenzoates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tryptophan

2021
Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression.
    Journal of affective disorders, 2021, 09-01, Volume: 292

    Topics: Antiviral Agents; Cytokines; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Ribavirin

2021
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C.
    Psychiatry research, 2017, Volume: 253

    Topics: Adult; Antiviral Agents; Coinfection; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Ribavirin

2017
Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2019, Volume: 28, Issue:9

    Topics: Antiviral Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Prospective Studies; Psychiatric Status Rating Scales; Ribavirin

2019
Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
    Journal of psychosomatic research, 2014, Volume: 77, Issue:2

    Topics: Adult; Antiviral Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Personality Inventory; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Severity of Illness Index

2014
Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C.
    Psychopharmacology, 2016, Volume: 233, Issue:9

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antiviral Agents; Cohort Studies; Depressive Disorder, Major; Drug Interactions; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Norepinephrine; Prospective Studies; Ribavirin; Selective Serotonin Reuptake Inhibitors; Young Adult

2016
Psychomotor retardation and vulnerability to interferon alpha induced major depressive disorder: Prospective study of a chronic hepatitis C cohort.
    Journal of psychosomatic research, 2015, Volume: 79, Issue:6

    Topics: Adult; Aged; Antidepressive Agents; Antiviral Agents; Depression; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Ribavirin

2015
Is the interferon-α-triggered depressive episode a self-limited kind of depression? Four cases of persistent affective symptoms after antiviral treatment in HCV-infected individuals.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:7

    Topics: Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Hospitals, University; Humans; Interferon alpha-2; Interferon-alpha; Long-Term Care; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Risk Factors; Substance Withdrawal Syndrome

2010
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:2

    Topics: Adult; Antiviral Agents; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Failure

2010
The association between viral clearance and depression in patients with hepatitis C receiving interferon-alpha and ribavirin.
    Brain, behavior, and immunity, 2005, Volume: 19, Issue:4

    Topics: Comorbidity; Depressive Disorder, Major; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Treatment Failure; Treatment Outcome; Viral Load

2005
Major depressive episode with psychotic features induced by pegylated interferon-alpha-2b and ribavirin treatment.
    International clinical psychopharmacology, 2005, Volume: 20, Issue:5

    Topics: Adult; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Psychoses, Substance-Induced; Recombinant Proteins; Ribavirin

2005
Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C.
    Alimentary pharmacology & therapeutics, 2006, Oct-15, Volume: 24, Issue:8

    Topics: Antiviral Agents; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Failure

2006